WEST PHARMACEUTICAL SERVICES, INC. Unternehmen West Pharmaceutical Services, Inc. BOERSE MUENCHEN
Aktien
864330
US9553061055
WPS
Medizinische Versorgung
|
Realtime
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
| 303.8 EUR | +2.05% |
|
-5.49% | -6.56% |
Kurzporträt
- selbst hergestellte Produkte (81,8%);
- im Auftrag hergestellte Produkte (18,2%).
Der Nettoumsatz verteilt sich geografisch wie folgt: Vereinigte Staaten (42,3%), Deutschland (16,8%), Irland (8,7%), Frankreich (7,5%), Europa (12,1%) und andere (12,6%).
Umsatz nach Geschäftsbereich
| USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
Proprietary Products
81,3
%
| 2 407 | 83,4 % | 2 397 | 81,3 % | -0.39% |
Contract-Manufactured Products
18,7
%
| 480 | 16,6 % | 553 | 18,7 % | +15.01% |
Umsatz je Region
| USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
United States
42,0
%
| 1 287 | 44,6 % | 1 239 | 42,0 % | -3.73% |
Germany
13,8
%
| 399 | 13,8 % | 406 | 13,8 % | +1.86% |
Other European Countries
13,2
%
| 359 | 12,4 % | 388 | 13,2 % | +8.05% |
Other
11,8
%
| 364 | 12,6 % | 349 | 11,8 % | -4.34% |
Ireland
9,7
%
| 240 | 8,3 % | 286 | 9,7 % | +18.89% |
France
9,6
%
| 238 | 8,2 % | 283 | 9,6 % | +18.92% |
Manager
| Manager | Titel | Alter | Seit |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 55 | 24.04.15 |
Bernard Birkett
DFI | Director of Finance/CFO | 55 | 21.06.18 |
Silji Abraham
CTO | Chief Tech/Sci/R&D Officer | 52 | 26.02.18 |
Quintin Lai
IRC | Investor Relations Contact | 57 | 11.01.16 |
Robert Segura
PRN | Corporate Officer/Principal | - | 01.09.21 |
| Corporate Officer/Principal | 50 | - | |
Kimberly MacKay
LAW | General Counsel | 58 | 01.12.20 |
Chad Winters
AUD | Comptroller/Controller/Auditor | 45 | 01.10.19 |
Annette Favorite
HRO | Human Resources Officer | 59 | 05.10.15 |
Chris Ryan
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
| Aufsichtsräte | Titel | Alter | Seit |
|---|---|---|---|
Douglas Michels
BRD | Director/Board Member | 66 | 01.02.11 |
Eric Green
CEO | Chief Executive Officer | 55 | 24.04.15 |
Paolo Pucci
BRD | Director/Board Member | 63 | 12.09.16 |
William Feehery
BRD | Director/Board Member | 54 | 01.02.12 |
Robert Friel
BRD | Director/Board Member | 68 | 17.02.20 |
Thomas Hofmann
BRD | Director/Board Member | 72 | 01.10.07 |
Myla Lai-Goldman
BRD | Director/Board Member | 66 | 17.02.14 |
Mark Buthman
BRD | Director/Board Member | 63 | 01.02.11 |
Molly Joseph
BRD | Director/Board Member | 50 | 19.08.21 |
Deborah Keller
BRD | Director/Board Member | 61 | 01.06.17 |
Anteilsklasse
| Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
|---|---|---|---|---|---|
| Aktie A | 1 | 75 143 157 | 72 425 015 ( 96,38 %) | 2 300 000 ( 3,061 %) | 96,38 % |
Unternehmenskontakt
West Pharmaceutical Services, Inc.
530 Herman O. West Drive
19341-0645, Exton
+610 594 2900
http://www.westpharma.com
Konzerngesellschaften
| Name | Kategorie und Branche |
|---|---|
TGPR Holdings Ltd.
 TGPR Holdings Ltd. Medical SpecialtiesHealth Technology Part of West Pharmaceutical Services, Inc., TGPR Holdings Ltd. is an Irish company. The company is located in Ireland. |
Medical Specialties
|
West Pharmaceutical Services Holding GmbH
 West Pharmaceutical Services Holding GmbH Pharmaceuticals: MajorHealth Technology Part of West Pharmaceutical Services, Inc., West Pharmaceutical Services Holding GmbH is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The company is based in Eschweiler, Germany. 4040/40 delivers reliability and functionality that comes from a scientifically developed formulation paired with West's leadership in injectable drug containment and administration. West's Lined Seals can be used for single-dose or multi-dose applications and meet specifications to ensure strong device performance. Pharmaceutical, biotechnology, generic, and medical device companies trust our ability to deliver consistent high-quality and technologically advanced containment and delivery solutions. The CEOs are George Lloyd Miller and Stephan Selke. The German company was founded in 1987. |
Pharmaceuticals: Major
|
West Pharmaceutical Services Singapore Pte Ltd.
 West Pharmaceutical Services Singapore Pte Ltd. Pharmaceuticals: MajorHealth Technology Part of West Pharmaceutical Services, Inc., West Pharmaceutical Services Singapore Pte Ltd. is a company that provides packaging components and delivery systems for injectable drugs and healthcare products. The company is based in Singapore, Singapore. Pharmaceutical, biotechnology, generic and medical device companies rely on their ability to deliver consistent high-quality and technologically advanced containment and delivery solutions. The Singaporean company offers Daikyo D Sigma® components that are designed to reduce particulate, mitigate patient safety risks and reduce variability for injectable medicines. Additionally, West’s Contract Manufacturing offers Pharmaceutical & Medical Device components to help customers develop and commercialize medical devices, drug delivery systems and combination products as per regulatory requirements (FDA & EMA). |
Pharmaceuticals: Major
|
West Pharmaceutical Services Deutschland GmbH & Co. KG
 West Pharmaceutical Services Deutschland GmbH & Co. KG Medical SpecialtiesHealth Technology Part of West Pharmaceutical Services, Inc., West Pharmaceutical Services Deutschland GmbH & Co. KG is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The company is based in Eschweiler, Germany. Pharmaceutical, biotechnology, generic and medical device companies trust their ability to deliver consistent high-quality and technologically advanced containment and delivery solutions. The CEOs are George Lloyd Miller, Stephan Selke. West Pharmaceutical Services Deutschland offers products such as 4040/40, which delivers reliability and functionality that comes from a scientifically developed formulation paired with West's leadership in injectable drug containment and administration. Additionally, West's Lined Seals can be used for single-dose or multi-dose applications and meet specifications to ensure strong device performance. The German company was founded in 1997. |
Medical Specialties
|
Medimop Medical Projects Ltd.
 Medimop Medical Projects Ltd. Medical SpecialtiesHealth Technology Part of West Pharmaceutical Services, Inc., Medimop Medical Projects Ltd. develops medical devices used as pharmaceutical connectors. The company is based in Raanana, Israel. Medimop Medical Projects was acquired by West Pharmaceutical Services, Inc. on July 05, 2005 for $41.80 million. |
Medical Specialties
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
| % 1. Jan. | Kap. | |
|---|---|---|
| -5.13% | 181 Mrd. | |
| -3.80% | 105 Mrd. | |
| -3.31% | 67.55 Mrd. | |
| -6.16% | 46.39 Mrd. | |
| +4.82% | 40.93 Mrd. | |
| +20.92% | 31.63 Mrd. | |
| +12.18% | 24.28 Mrd. | |
| -13.27% | 21.95 Mrd. | |
| -1.64% | 21.4 Mrd. |
- Börse
- Aktien
- 864330 Aktie
- 864330 Aktie
- Unternehmen West Pharmaceutical Services, Inc.
